logo

Eloxx Pharmaceuticals, Inc. (ELOX)



Trade ELOX now with
  Date
  Headline
9/23/2019 7:52:59 AM CF Foundation And Eloxx To Form Joint Program Advisory Group Focused On Development Of ELX-02 For Cystic Fibrosis
6/20/2019 8:40:45 AM Eloxx Prices Public Offering Of 3.33 Mln Shares At $9.00 Per Share
3/8/2019 7:14:39 AM Eloxx Pharma Q4 Loss $14.0 Mln Or $0.40/Shr Vs Loss Of $11.4 Mln Or $0.52/Shr Last Year
11/8/2018 7:18:49 AM Eloxx Pharma Q3 Loss $11.2 Mln Or $0.32/Shr Vs Loss $4.0 Mln Or $1.15/Shr Last Year
6/18/2018 7:31:43 AM Eloxx Appoints Neil Belloff, EVP, General Counsel And Corporate Secretary
6/11/2018 7:31:10 AM Neovasc Elects Steve Rubin As Chairman Of Board
6/8/2018 11:02:02 AM Eloxx Pharmaceuticals Presents Positive New Data For Lead Investigational Drug, ELX-02
5/3/2018 3:36:16 AM In The Spotlight: Eloxx Pharma